Fasciite necrotizante por neoplasia de colon descendente. Descriçao de caso e revisao da literatura

Vieira, Maria Jose Femenias; Habr-Gama, Angelita; Turcato, Gilberto; Damico, Francisco Max; Gama-Rodrigues, Joaquim.
Rev. bras. colo-proctol ; 13(1): 1-4, jan.-mar. 1993. ilus
Artigo em Português | LILACS | ID: lil-136456

Documentos relacionados

  1. Atlas Drugged.
  2. Patterns of differential expression by association in omic data using a new measure based on ensemble learning.
  3. Whittling down the bacterial subspecies that might drive colon cancer.
  4. Noncanonical Wnt signaling promotes colon tumor growth, chemoresistance and tumor fibroblast activation.
  5. Constructing and validating a risk model based on neutrophil-related genes for evaluating prognosis and guiding immunotherapy in colon cancer.
  6. Expression, prognostic value and potential immunotherapeutic target of COL1A1 in colon cancer.
  7. Clinical plasma cells-related genes to aid therapy in colon cancer.
  8. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
  9. An Activated Dendritic-Cell-Related Gene Signature Indicative of Disease Prognosis and Chemotherapy and Immunotherapy Response in Colon Cancer Patients.
  10. An Increase in Mucin2 Expression Is Required for Colon Cancer Progression Mediated by L1.